-
Scientific Organizers: Anwesha Dey, Laura D. Attardi, and Mariam Jamal-Hanjani
Important Deadlines
Meeting Summary
This conference focuses attention on the cancer cell itself, exploring the cell-intrinsic mechanisms that drive carcinogenesis and cancer progression. The meeting emphasizes understanding how genetic, epigenetic, and metabolic changes within cancer cells contribute to tumor evolution, heterogeneity, and plasticity, in order to provide new insights into potential strategies for therapeutic interventions. While other meetings in the field focus on the tumor microenvironment and crosstalk between cells within the tumor, this meeting will take a distinct approach to pinpoint cancer cell vulnerabilities, and therapeutic strategies targeting intrinsic pathways. By bringing together experts from academia, industry, and medicine to examine the underpinnings of tumor development and evolution, we will inspire new approaches to cancer treatment.
In the video below, Dr. Anwesha Dey from Genentech, talks about what to expect from this meeting and why you should attend:
Additionally, check out the speaker highlights:
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
GRANT RECOGNITION:
Federal Funding provided by the National Institutes of Health:
Funding for this conference was made possible (in part) by 1R13CA306199-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To access the NIH Safe Environment Policy, please click here.